[
Brandon M., Baldi P., Wallace D.C. (2006). Mitochondrial mutations in cancer. Oncogene, 25: 4647–4662.
]Search in Google Scholar
[
Brown T.P., Ganapathy V. (2020). Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol. Ther., 206: 107451.
]Search in Google Scholar
[
Bulduk B.K., Kiliç H.B., Bekircan-Kurt C.E., Haliloǧlu G., Erdem Özdamar S., Topaloǧlu H., Kocaefe Y.Ç. (2020). A novel amplification-refractory mutation system-PCR strategy to screen MT-TL1 pathogenic variants in patient repositories. Gen. Test. Mol. Biomark., 24: 165–170.
]Search in Google Scholar
[
Chen S., Zhou Y., Chen Y., Gu J. (2018). Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics, 34: i884–i890.
]Search in Google Scholar
[
Christianson T.W., Clayton D.A. (1986). In vitro transcription of human mitochondrial DNA: Accurate termination requires a region of DNA sequence that can function bidirectionally. Proc. Nat. Acad. Sci. USA, 83: 6277–6281.
]Search in Google Scholar
[
Christianson T.W., Clayton D.A. (1988). A tridecamer DNA sequence supports human mitochondrial RNA 3’-end formation in vitro. Mol. Cell. Biol., 8: 4502–4509.
]Search in Google Scholar
[
Cullen J.M., Page R., Misdorp W. (2008). An overview of cancer pathogenesis, diagnosis, and management. Tum. Domest. Anim., Iowa State Press, Ames, Iowa, USA, pp. 1–44.
]Search in Google Scholar
[
D’Souza A.R., Minczuk M. (2018). Mitochondrial transcription and translation: Overview. Essays Biochem., 62: 309–320.
]Search in Google Scholar
[
den Dunnen J.T., Dalgleish R., Maglott D.R., Hart R.K., Greenblatt M.S., Mcgowan-Jordan J., Roux A.F., Smith T., Antonarakis S.E., Taschner P.E.M. (2016). HGVS Recommendations for the description of sequence variants: 2016 Update. Human Mut., 37: 564–569.
]Search in Google Scholar
[
Dobson J.M. (2013). Breed-predispositions to cancer in pedigree dogs. ISRN Vet. Sci., 2013: 941275.
]Search in Google Scholar
[
El-Hattab A.W., Adesina A.M., Jones J., Scaglia F. (2015). MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol. Genet. Metab., 116: 4–12.
]Search in Google Scholar
[
Fernández-Silva P., Enriquez J.A., Montoya J. (2003). Replication and transcription of mammalian mitochondrial DNA. Exp. Physiol., 88: 41–56.
]Search in Google Scholar
[
Goldschmidt M.H., Peña L., Rasotto R., Zappulli V. (2011). Classification and grading of canine mammary tumors. Vet. Pathol., 48: 117–131.
]Search in Google Scholar
[
Grzybowska-Szatkowska L., Slaska B. (2012). Polymorphisms in genes encoding mt-tRNA in female breast cancer in Poland. Mitochondrial DNA, 23: 106–111.
]Search in Google Scholar
[
Grzybowska-Szatkowska L., Ślaska B. (2014). Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. J. Appl. Genet, 55: 173–181.
]Search in Google Scholar
[
Hebert P.D.N., Dewaard J.R., Landry J.F. (2010). DNA barcodes for 1/1000 of the animal Kingdom. Biol. Lett., 6: 359–362.
]Search in Google Scholar
[
Helm M., Brulé H., Friede D., Giegé R., Pütz D., Florentz C. (2000). Search for characteristic structural features of mammalian mitochondrial tRNAs. RNA, 6: 1356–1379.
]Search in Google Scholar
[
Hyvärinen A.K., Pohjoismäki J.L.O., Reyes A., Wanrooij S., Yasukawa T., Karhunen P.J., Spelbrink J.N., Holt I.J., Jacobs H.T. (2007). The mitochondrial transcription termination factor mTERF modulates replication pausing in human mitochondrial DNA. Nuc. Acids Res., 35: 6458–6474.
]Search in Google Scholar
[
Imes D.L., Wictum E.J., Allard M.W., Sacks B.N. (2012). Identification of single nucleotide polymorphisms within the mtDNA genome of the domestic dog to discriminate individuals with common HVI haplotypes. Foren. Sci. Int. Genet., 6: 630–639.
]Search in Google Scholar
[
Kim K.S., Lee S.E., Jeong H.W., Ha J.H. (1998). The complete nucleotide sequence of the domestic dog (Canis familiaris) mitochondrial genome. Mol. Phylogenet. Evol., 10: 210–220.
]Search in Google Scholar
[
Kowal K., Ślaska B., Bownik A., Horecka B., Gawor J., Śmiech A., Tkaczyk A. (2019). Analysis of Mitochondrial genome from labrador (Canis lupus familiaris) with mammary gland tumour reveals novel mutations and polymorphisms. Ann. Anim. Sci., 19: 619–632.
]Search in Google Scholar
[
Kowal K., Tkaczyk A., Pierzchała M., Bownik A., Ślaska B. (2020). Identification of mitochondrial DNA (NUMTs) in the nuclear genome of Daphnia magna. Int. J. Mol. Sci., 21.10.3390/ijms21228725769918433218217
]Search in Google Scholar
[
Kruse B., Narasimhan N., Attardi G. (1989). Termination of transcription in human mitochondria: Identification and purification of a DNA binding protein factor that promotes termination. Cell, 58: 391–397.
]Search in Google Scholar
[
Larman T.C., DePalma S.R., Hadjipanayis A.G., Protopopov A., Zhang J., Gabriel S.B., Chin L., Seidman C.E., Kucherlapati R., Seidman J.G. (2012). Spectrum of somatic mitochondrial mutations in five cancers. Proc. National Academy of Sciences of the United States of America, 109: 14087–14091.
]Search in Google Scholar
[
Lorenc A., Bryk J., Golik P., Kupryjańczyk J., Ostrowski J., Pronicki M., Semczuk A., Szołkowska M., Bartnik E. (2003). Homosplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion, 3: 119–124.
]Search in Google Scholar
[
Lott M.T., Leipzig J.N., Derbeneva O., Michael Xie H., Chalkia D., Sarmady M., Procaccio V., Wallace D.C. (2013). MtDNA variation and analysis using Mitomap and Mitomaster. Curr. Prot. Bioinf., 44.10.1002/0471250953.bi0123s44425760425489354
]Search in Google Scholar
[
Lowe T.M., Chan P.P. (2016). tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes. Nucleid Acids Res., 44: W54–W57.
]Search in Google Scholar
[
Martin M., Cho J., Cesare A.J., Griffith J.D., Attardi G. (2005). Termination factor-mediated DNA loop between termination and initiation sites drives mitochondrial rRNA synthesis. Cell, 123: 1227–1240.
]Search in Google Scholar
[
Mayr J.A., Meierhofer D., Zimmermann F., Feichtinger R., Kögler C., Ratschek M., Schmeller N., Sperl W., Kofler B. (2008). Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin. Canc. Res., 14: 2270–2275.
]Search in Google Scholar
[
Meierhofer D., Mayr J.A., Fink K., Schmeller N., Kofler B., Sperl W. (2006). Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism. Brit. J. Cancer, 94: 268–274.
]Search in Google Scholar
[
Moraes C.T., Ciacci F., Bonilla E., Jansen C., Hirano M., Rao N., Lovelace R.E., Rowland L.P., Schon E.A., DiMauro S. (1993). Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis: Is the tRNALeu(UUR) gene an etiologic hot spot? J. Clin. Invest., 92: 2906–2915.
]Search in Google Scholar
[
Okonechnikov K., Golosova O., Fursov M., Varlamov A., Vaskin Y., Efremov I., German Grehov O.G., Kandrov D., Rasputin K., Syabro M., Tleukenov T. (2012). Unipro UGENE: A unified bioinformatics toolkit. Bioinformatics, 28: 1166–1167.
]Search in Google Scholar
[
Pereira L., Van Asch B., Amorim A. (2004). Standardisation of nomenclature for dog mtDNA D-loop: A prerequisite for launching a Canis familiaris database. Forensic Sci. Int., 141: 99–108.
]Search in Google Scholar
[
Queen R.A., Steyn J.S., Lord P., Elson J.L. (2017). Mitochondrial DNA sequence context in the penetrance of mitochondrial t-RNA mutations: A study across multiple lineages with diagnostic implications. PLoS ONE., 12.10.1371/journal.pone.0187862569786229161289
]Search in Google Scholar
[
Rahman S., Hanna M.G. (2009). Diagnosis and therapy in neuromuscular disorders: Diagnosis and new treatments in mitochondrial diseases. J. Neurol. Neurosur. Psych., 80.10.1136/jnnp.2008.15827919684231
]Search in Google Scholar
[
Singh B., Modica-Napolitano J.S., Singh K.K. (2017 a). Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome. Semin. Cancer Biol., 47: 1–17.10.1016/j.semcancer.2017.05.004568189328502611
]Search in Google Scholar
[
Singh K.K., Modica-Napolitano J.S. (2017 b). Special issue: Mitochondria in cancer. Semin. Cancer Biol., 47: 4–6.10.1016/j.semcancer.2017.10.01329157537
]Search in Google Scholar
[
Singh K.K., Choudhury A.R., Tiwari H.K. (2017 c). Numtogenesis as a mechanism for development of cancer. Semin. Cancer Biol., 47: 101–109.10.1016/j.semcancer.2017.05.003568394728511886
]Search in Google Scholar
[
Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Surdyka M., Śmiech A. (2013). Nuclear and mitochondrial DNA mutation in human and canine tumors. Med. Weter., 69: 195–202.
]Search in Google Scholar
[
Slaska B., Surdyka M., Brodzki A., Nisztuk S., Gurgul A., Bugno-Poniewierska M., Miech A., Roanska D., Orzelski M. (2014 a). Mitochondrial D-loop mutations can be detected in sporadic malignant tumours in dogs. Bull. Vet. Inst. Pulawy, 58: 631–637.10.2478/bvip-2014-0096
]Search in Google Scholar
[
Slaska B., Grzybowska-Szatkowska L., Surdyka M., Nisztuk S., Rozanska D., Rozanski P., Smiech A., Orzelski M. (2014 b). Mitochondrial D-loop mutations and polymorphisms are connected with canine malignant cancers. Mitochond. DNA, 25: 238–243.10.3109/19401736.2013.79205423656294
]Search in Google Scholar
[
Sonney S., Leipzig J., Lott M.T., Zhang S., Procaccio V., Wallace D.C., Sondheimer N. (2017). Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP. PLos Comput. Biol., 13.10.1371/journal.pcbi.1005867573950429227991
]Search in Google Scholar
[
Stacey S.N., Manolescu A., Sulem P., Rafnar T., Gudmundsson J., Gudjonsson S.A., Masson G., Jakobsdottir M., Thorlacius S., Helgason A., Aben K.K., Strobbe L.J., Albers-Akkers M.T., Swinkels D.W., Henderson B.E., Kolonel L.N., Le Marchand L., Millastre E., Andres R., et al. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet., 39: 865–869.
]Search in Google Scholar
[
Sun S., Wu C., Yang C., Chen J., Wang X., Nan Y., Huang Z., Ma L. (2019). Prognostic roles of mitochondrial transcription termination factors in non-small cell lung cancer. Oncol. Lett., 18: 3453–3462.
]Search in Google Scholar
[
Surdyka M., Slaska B. (2017). Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour. Vet. Comp. Oncol., 15: 820–828.
]Search in Google Scholar
[
Tkaczyk A., Kowal K., Ślaska B. (2020). Mitochondrial D-loop informative SNPs in identification of dog’s breed. Med. Weter., 76: 6394–2020.
]Search in Google Scholar
[
Wallace D.C. (2012). Mitochondria and cancer. Nat. Rev. Cancer, 12: 685–698.
]Search in Google Scholar
[
Wallace K.B. (2014). Drug-induced mitochondrial neuropathy in children: A conceptual framework for critical windows of development. J. Child Neurol. SAGE Publ. Inc., 29: 1241–1248.
]Search in Google Scholar
[
Wheeler J.H., Young C.K.J., Young M.J. (2019). Analysis of human mitochondrial DNA content by southern blotting and nonradioactive probe hybridization. Curr. Prot. Toxicol., 80.10.1002/cptx.75658160630982231
]Search in Google Scholar
[
Xu B., Reznik E., Tuttle R.M., Knauf J., Fagin J.A., Katabi N., Dogan S., Aleynick N., Seshan V., Middha S., Enepekides D., Casadei G.P., Solaroli E., Tallini G., Ghossein R., Ganly I. (2019). Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features. Endocrine, 64: 97–108.
]Search in Google Scholar
[
Young M.J., Copeland W.C. (2016). Human mitochondrial DNA replication machinery and disease. Curr. Opin. Genet. Dev., 38: 52–62.
]Search in Google Scholar
